BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7492457)

  • 1. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy?
    Stokkel MP; Kwa BM; Pauwels EK
    Br J Clin Pract; 1995; 49(5):235-8. PubMed ID: 7492457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer.
    Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R
    J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-111 octreotide imaging in staging of small cell lung cancer.
    Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
    Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer.
    Kwekkeboom DJ; Krenning EP; Bakker WH; Oei HY; Splinter TA; Kho GS; Lamberts SW
    J Nucl Med; 1991 Oct; 32(10):1845-8. PubMed ID: 1655997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
    Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
    Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
    Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
    Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
    J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of octreotide scintigraphy in patients with lung cancer.
    Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
    Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor imaging in small cell lung cancer.
    Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
    Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients.
    Tzannou IA; Karapanagiotou EM; Charpidou A; Dilana K; Alamara C; Christakopoulou I; Georgiou E; Syrigos KN
    Am J Clin Oncol; 2007 Oct; 30(5):503-6. PubMed ID: 17921711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor scintigraphy in the staging of small cell lung cancer.
    Bohuslavizki KH; Brenner W; Günther M; Eberhardt JU; Jahn N; Tinnemeyer S; Wolf H; Sippel C; Clausen M; Gatzemeier U; Henze E
    Nucl Med Commun; 1996 Mar; 17(3):191-6. PubMed ID: 8692484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.
    Vaccarili M; Lococo A; Fabiani F; Staffilano A
    Tumori; 2000; 86(3):224-8. PubMed ID: 10939603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
    O'Byrne KJ; Ennis JT; Freyne PJ; Clancy LJ; Prichard JS; Carney DN
    Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide scintigraphy for small cell lung carcinoma: past, present or future?
    Stokkel MP; Pauwels EK
    Eur J Nucl Med; 1994 Dec; 21(12):1276-8. PubMed ID: 7875163
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
    Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A
    Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer.
    Crippa F; Bombardieri E; Chiti A; Soresi E; Boffi R; Buraggi GL
    J Nucl Biol Med (1991); 1994 Dec; 38(4):576-8. PubMed ID: 7786920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
    Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
    Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
    Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.
    Kirsch CM; von Pawel J; Grau I; Tatsch K
    Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.